Overview
Neuromodulation Market Access is a company based in Cambridge that focuses on the Medical Technology and Healthcare Innovation sector. Founded in 2022, the company supports the development and execution of go-to-market strategies specifically for devices that utilize neuromodulation science. Neuromodulation Market Access was established following the founders' experiences in commercializing a Class IIa medical device across the UK, Europe, and other regions. The company aims to facilitate a faster and more cost-effective adoption and reimbursement process for medical technologies, benefiting patients and healthcare systems globally. Neuromodulation Market Access serves a diverse clientele, ranging from start-ups to large MedTech companies, and emphasizes professionalism and real-world experience in its operations.
Details
- Category
- Business Consulting and Services
- Headquarters
- Cambridge
- Type
- Privately Held
- Founded
- 2022
- Specialties
- Neuromodulation, Commercial Strategy, Medical Technology, Healthcare, Health technology Assessments, Reimbursement, Innovation, Go-to-Market strategies, Medical Devices, and Direct-to-Consumer sales
- Locations
- Cambridge, GB